Name
OÜ A & D Hambaravi
Registry code
10914178
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
06.03.2003 (21)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86231 - Provision of dental treatment
448 927 €
49 042 €
11%
3 982 €
(estimate is approximate)
62 236 €
4
Submitted
No tax arrears
79%
52%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Andres Korrovits 02.03.1972 (52) | 50% - 1 278.00 EUR | Board member | Direct ownership | Founder |
| Diana Dukan 26.03.1973 (51) | 50% - 1 278.00 EUR | Board member | Direct ownership | Founder |
| 2019 03.03.2020 | 2020 22.06.2021 | 2021 06.05.2022 | 2022 02.06.2023 | 2023 28.02.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 398 756 € | 242 904 € | 428 332 € | 467 579 € | 448 927 € |
| Net profit (loss) for the period | 79 604 € | 51 352 € | 58 880 € | 67 174 € | 49 042 € |
| Profit Margin | 20% | 21% | 14% | 14% | 11% |
| Current Assets | 120 470 € | 121 586 € | 108 660 € | 114 465 € | 93 621 € |
| Fixed Assets | 576 € | 0 € | 0 € | 0 € | 0 € |
| Total Assets | 121 046 € | 121 586 € | 108 660 € | 114 465 € | 93 621 € |
| Current Liabilities | 33 180 € | 52 367 € | 32 639 € | 31 270 € | 31 385 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 87 866 € | 69 219 € | 76 021 € | 83 195 € | 62 236 € |
| Employees | 4 | 4 | 4 | 4 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 28 361.1 € | 28 725.54 € | 5 |
| 2023 Q4 | - | 24 918.73 € | 24 294.31 € | 5 |
| 2023 Q3 | - | 32 896.71 € | 31 499.57 € | 5 |
| 2023 Q2 | - | 31 263.28 € | 26 284.43 € | 5 |
| 2023 Q1 | - | 23 719.45 € | 25 372.12 € | 5 |
| 2022 Q4 | - | 29 916.05 € | 28 039.07 € | 4 |
| 2022 Q3 | - | 27 562.25 € | 28 023.47 € | 4 |
| 2022 Q2 | - | 28 236.7 € | 24 838.5 € | 4 |
| 2022 Q1 | - | 22 458.29 € | 24 019.62 € | 4 |
| 2021 Q4 | - | 20 101.72 € | 20 294.49 € | 4 |
| 2021 Q3 | - | 30 243.82 € | 27 085.95 € | 4 |
| 2021 Q2 | - | 25 003.8 € | 22 446.55 € | 4 |
| 2021 Q1 | - | 22 002.12 € | 23 492.01 € | 4 |
| 2020 Q4 | - | 23 425.56 € | 22 869.16 € | 4 |
| 2020 Q3 | - | 19 856.82 € | 16 683.95 € | 4 |
| 2020 Q2 | - | 11 396.18 € | 12 220.94 € | 4 |
| 2020 Q1 | - | 30 415.35 € | 24 627.33 € | 4 |
